BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12843335)

  • 1. Characterisation of repeat and palindrome elements in patients harbouring single deletions of mitochondrial DNA.
    Solano A; Gámez J; Carod FJ; Pineda M; Playán A; López-Gallardo E; Andreu AL; Montoya J
    J Med Genet; 2003 Jul; 40(7):e86. PubMed ID: 12843335
    [No Abstract]   [Full Text] [Related]  

  • 2. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples.
    De Coo IF; Gussinklo T; Arts PJ; Van Oost BA; Smeets HJ
    J Neurol Sci; 1997 Jul; 149(1):37-40. PubMed ID: 9168163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
    Wang ZX; Yuan Y; Gao F; Qi Y; Shen DG; Chen QT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):273-8. PubMed ID: 12903032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and quantification of mitochondrial DNA deletions.
    Soong NW; Arnheim N
    Methods Enzymol; 1996; 264():421-31. PubMed ID: 8965714
    [No Abstract]   [Full Text] [Related]  

  • 5. Deletion screening of mitochondrial DNA via multiprimer DNA amplification.
    Ernst BP; Wilichowski E; Wagner M; Hanefeld F
    Mol Cell Probes; 1994 Feb; 8(1):45-9. PubMed ID: 8028607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protocol for detection of mitochondrial DNA deletions: characterization of a novel deletion.
    Coulter-Mackie MB; Applegarth DA; Toone JR; Gagnier L
    Clin Biochem; 1998 Nov; 31(8):627-32. PubMed ID: 9876894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single deletion of mitochondrial DNA: CPEO, Kearns-Sayre syndrome].
    Arisato T; Higuchi I; Nakagawa M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():458-61. PubMed ID: 12013912
    [No Abstract]   [Full Text] [Related]  

  • 8. 3.1-kb deletion of mitochondrial DNA in a patient with Kearns-Sayre syndrome.
    Klopstock T; Bischof F; Gerok K; Deuschl G; Seibel P; Ketelsen UP; Reichmann H
    Acta Neuropathol; 1995; 90(2):126-9. PubMed ID: 7484086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].
    Barrientos A; Casademont J; Grau JM; Cardellach F; Montoya J; Estivill X; Urbano-Márquez A; Nunes V
    Med Clin (Barc); 1995 Jul; 105(5):180-4. PubMed ID: 7630231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia.
    Kiyomoto BH; Tengan CH; Moraes CT; Oliveira AS; Gabbai AA
    J Neurol Sci; 1997 Nov; 152(2):160-5. PubMed ID: 9415537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia.
    Moslemi AR; Melberg A; Holme E; Oldfors A
    Ann Neurol; 1996 Nov; 40(5):707-13. PubMed ID: 8957011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes.
    Sadikovic B; Wang J; El-Hattab AW; Landsverk M; Douglas G; Brundage EK; Craigen WJ; Schmitt ES; Wong LJ
    PLoS One; 2010 Dec; 5(12):e15687. PubMed ID: 21187929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic analysis of mitochondrial DNA in a patient with Kearns-Sayre syndrome containing a novel 7629-bp deletion.
    Montiel-Sosa JF; Herrero MD; Munoz Mde L; Aguirre-Campa LE; Pérez-Ramírez G; García-Ramírez R; Ruiz-Pesini E; Montoya J
    Mitochondrial DNA; 2013 Aug; 24(4):420-31. PubMed ID: 23391298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPEO and KSS differ in the percentage and location of the mtDNA deletion.
    López-Gallardo E; López-Pérez MJ; Montoya J; Ruiz-Pesini E
    Mitochondrion; 2009 Sep; 9(5):314-7. PubMed ID: 19410662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA.
    Schon EA; Rizzuto R; Moraes CT; Nakase H; Zeviani M; DiMauro S
    Science; 1989 Apr; 244(4902):346-9. PubMed ID: 2711184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR.
    Kleinle S; Wiesmann U; Superti-Furga A; Krähenbühl S; Boltshauser E; Reichen J; Liechti-Gallati S
    Hum Genet; 1997 Oct; 100(5-6):643-50. PubMed ID: 9341886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population.
    Remes AM; Majamaa-Voltti K; Kärppä M; Moilanen JS; Uimonen S; Helander H; Rusanen H; Salmela PI; Sorri M; Hassinen IE; Majamaa K
    Neurology; 2005 Mar; 64(6):976-81. PubMed ID: 15781811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of mitochondrial DNA deletion in paraffin embedded muscle tissues from patients with KSS and CPEO.
    Kim SH; Chi JG; Reith A; Kadenbach B
    Biochim Biophys Acta; 1997 May; 1360(3):193-5. PubMed ID: 9197460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic progressive external ophthalmoplegia (CPEO), Kearns-Sayre syndrome (KSS)].
    Ishikawa H; Nishino I
    Ryoikibetsu Shokogun Shirizu; 2001; (36):153-6. PubMed ID: 11596351
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies.
    Zeviani M; Gellera C; Pannacci M; Uziel G; Prelle A; Servidei S; DiDonato S
    Ann Neurol; 1990 Jul; 28(1):94-7. PubMed ID: 2375642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.